SBC Medical Group Holdings Incorporated (SBC)
Official siteINDUSTRIALS • CONSULTING SERVICES • NASDAQ
Market Cap: $755.92M
Last updated: Nov 17, 2026 at 11:06 AM ET
SBC Medical Group Holdings Incorporated (SBC) P/E Ratio & Valuation Multiples
SBC Medical Group Holdings (SBC) trades at 12.4x trailing earnings and 3.3x sales. Its forward P/E is 14.1x. The median P/E across 7 similar companies is 16.3x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 12.1% lower over the next year. Its free cash flow yield is 15.8%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 12.4x |
| Forward P/E | 14.1x |
| Price to sales | 3.3x |
| Price to book | 2.2x |
| EV/EBITDA | 5.4x |
| Price to FCF | 6.3x |
|---|---|
| EV/FCF | 4.7x |
| PEG | 2.8 |
| FCF yield | 15.8% |
As of Nov 17, 2026
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About SBC
What is SBC's forward P/E ratio?
SBC Medical Group Holdings has a forward P/E ratio of 14.1x.
Is SBC stock overvalued?
GNG's valuation label for SBC is Fairly valued. Its P/E of 12.4x compares with a median of 16.3x across 7 similar companies.
What is SBC's price to sales ratio?
SBC Medical Group Holdings has a price to sales ratio of 3.3x.
What is SBC's PEG ratio?
SBC Medical Group Holdings has a PEG ratio of 2.8.
SBC pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors